A randomized clinical trial phase 3 on patients with linitis plastica on biological therapy for diffuse gastric cancer type 4 or large type 3 tumors showed that adjuvant chemotherapy S-1 (standard in Japan) with gastrectomy is no different than neoadjuvant chemotherapy and standard postoperative chemotherapy.